Key Insights Into Market Movements for Amgen Options
Market Insights on Amgen Options Activity
Recent trades in the options market indicate a bullish sentiment surrounding Amgen (NASDAQ: AMGN), capturing the attention of significant investors. It's noteworthy for retail traders to stay informed about such dynamics.
Today, unusual activity was detected in the options trading landscape, providing valuable information about potential price movements. Whether these trades are made by institutional investors or affluent individuals remains uncertain. However, the substantial volume often signals that knowledgeable entities might anticipate important developments.
Our analysis revealed 16 distinctive options trades related to Amgen, an unusual number for a single entity. The sentiment from these trades shows an equal division, with 43% leaning bullish and 43% bearish.
Among the trades, a notable figure emerged: 10 put options totaling $1,298,955 against 6 calls amounting to $312,382. This variance suggests differing strategies implemented by traders, providing important cues for market observers.
Understanding the Price Targets
Insights from the options volume and open interest over the past few months indicate a targeted price range for Amgen between $145.0 and $390.0. This analysis includes substantial input tracking the sentiment behind these high-value trades.
Examination of Volume and Open Interest Trends
The average open interest for Amgen options currently stands at 388.45, with the total trade volume hitting 3,084.00. Reviewing the data over the last 30 days clarifies the growing interest from traders within this strike price range.
Significant Options Trades Observed
Examining some of the largest trades gives insight into the strategies being deployed:
- Trade Type: Trade, Type: Put, Sentiment: Bullish, Expiration: 12/20/24, Price: $20.03, Total Price: $801.2K
- Trade Type: Sweep, Type: Put, Sentiment: Bearish, Expiration: 12/20/24, Price: $20.05, Total Price: $188.3K
- Trade Type: Trade, Type: Call, Sentiment: Neutral, Expiration: 01/17/25, Price: $188.7, Total Price: $132.0K
- Trade Type: Sweep, Type: Call, Sentiment: Bullish, Expiration: 11/15/24, Price: $7.3, Total Price: $70.0K
- Trade Type: Sweep, Type: Put, Sentiment: Bearish, Expiration: 09/27/24, Price: $4.1, Total Price: $52.4K
Profile of Amgen
Amgen stands tall in the biotechnology field, focusing on developing innovative human therapeutics. Some of their flagship products include Epogen and Aranesp for red blood cell enhancement, and Neupogen and Neulasta to boost immune function. Over the years, Amgen has expanded its portfolio to include essential treatments for a variety of conditions, including cancer and rare diseases.
In 2023, Amgen made headlines with the acquisition of Horizon, integrating several new therapies, notably for thyroid eye disease. The company also benefits from a well-rounded biosimilar portfolio, reinforcing its position in the biopharmaceutical landscape.
Current Market Status of Amgen
- Currently trading at $332.39, Amgen’s price has decreased by -0.96%.
- With a trading volume of 737,520, investor interest remains steady.
- Technical indicators suggest that the stock may be nearing overbought territory.
- The next earnings report is on the horizon, set to occur approximately 35 days from now.
Investing in options can be a double-edged sword, presenting both risks and opportunities for higher returns. Traders often leverage education, strategic adjustments, and timely insights into market conditions to navigate this landscape successfully.
Frequently Asked Questions
What is driving the recent options activity for Amgen?
Recent options activity for Amgen has been influenced by substantial trades in both put and call options, revealing mixed sentiments among investors.
What price targets are investors focusing on?
Investors appear to be targeting a price range for Amgen between $145.0 and $390.0 based on recent volume and interest trends.
What products are part of Amgen's portfolio?
Amgen’s product line includes treatments for various conditions, from cancer to rare diseases, with an emphasis on biotechnology-based therapies.
How does Amgen’s current stock price compare historically?
The current stock price of Amgen at $332.39 indicates a slight decrease, suggesting cautious market behavior.
What strategies should potential investors consider?
Prospective investors are encouraged to stay informed, analyze market trends, and utilize education to mitigate risks when trading options.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Elliott Investment Management's Bid for Citgo Explained
- Navigating the Turmoil of Hong Kong's Commercial Real Estate Market
- Market Experts Warn of Possible Stock Market Meltup Ahead
- Understanding Market Dynamics: Oil's Bearish Shift Explained
- Caution Ahead: European Markets Navigate Economic Challenges
- Mark Cuban's Evolving Political Views and Support for Trump
- Warren Buffett's Recent Stock Moves and Income Insights
- Impact of Recent Fed Rate Movements on Global Central Banks
- TD Bank Faces Criminal Charges for Money Laundering Issues
- Strategies for Strengthening Your Investment Portfolio Now
Recent Articles
- Coinbase Global, Inc. Faces Securities Class Action - Key Insights
- Understanding the Current Trends in UnitedHealth Group Options
- Invitation Homes Settles FTC Investigation with $48 Million Agreement
- Ventyx Biosciences Secures $27 Million Investment from Sanofi
- Market Insights: Oil Prices Rise While BioVie Shares Drop
- THOR Industries Unveils Groundbreaking Hybrid Class A Motorhome
- Washington Tech Coalition Launches Initiative for Diverse Talent
- Innovative Trash Can Design Enhances Waste Management Experience
- G-P Celebrated for Excellence in Global Employment Solutions
- WCG Unveils Improved AIMS Solution for Clinical Trials
- Equitable Bank Achieves Major Funding Success with New Notes
- SCCE & HCCA Welcomes New Members to Board of Directors
- Important Reminder for Orthofix Medical Investors on Deadline
- Balaji Srinivasan Links Bitcoin to Wealth and Health Preservation
- Intel's Future: Exploring Recent Developments and Investments
- Deadline Approaching for DexCom Securities Class Action
- Leadership Transition at ACADIA Pharmaceuticals: What to Expect
- Deadline Approaches for Arbor Realty Trust Investors' Claims
- Investment Boost for ATIS by Thompson Street Capital Partners
- Exploring the Recent Surge of Baidu Inc (NASDAQ: BIDU) Stock
- Key Details for Extreme Networks, Inc. Shareholders Alerted
- Pernod Ricard Strengthens Climate Commitments at NYC Event
- Navigating Nucor's Options Market Activity and Insights
- Entravision's Latest Poll Insights: Shaping Latino Voter Engagement
- Understanding Recent Trends in Capri Holdings Options Activity
- NationsBenefits Partners with RedSail to Enhance Pharmacy Care
- Market Insights into Barrick Gold's Future and Predictions
- Celebrating NAM's Legacy as Leading ADR Provider in Industry
- Explore Move-In Ready Homes at Toll Brothers' Regency
- Is McKesson Corporation Set for a Rebound in Stock Prices?
- Investors' Call to Action in Extreme Networks' Legal Battle
- Acadia Realty Trust Surges to 52-Week High with Strong Growth
- PureRed Strengthens Leadership Team with Strategic Appointments
- Citi Adjusts Price Target for XPeng, Anticipating Growth
- Innovative Blind Holder Device Revolutionizes Cleaning Experience
- Kontoor Brands Achieves Historic Stock Milestone at $79.26
- CRRC Debuts Innovative Eco-Trains for Sustainable Travel
- AirSculpt Technologies Expands with New Center in Deerfield
- How Business Leaders Unite for Sustainable Development Goals
- Exploring the Influence of Black Women in American Elections
- Purple Biotech's Stock Hits Low but Holds Future Promise
- SemiLEDS Corporation Hits 52-Week Low, Shares Reevaluate Future
- Citi Upgrades Li Auto Target Amid Strong EV Sales Surge
- Insights on Bitcoin Futures Activity and Market Trends
- Revolutionary EasyA x Polkadot University Set to Transform Blockchain Education
- Trusttoken and Truecoin Face SEC Charges Over Investor Fraud
- Discovering Warren Buffett's Remarkable Childhood Savings Journey
- Abstrax Hops Expands Flavor Range for Summer Creations
- Recognizing Outstanding Students with the Eric Dostie Scholarship
- Polyether Polyols Market Projects Sustainable Growth to 2034